Tumor cell proliferation and migration machinery

Tumor cell proliferation and migration machinery refers to the integrated biological systems and molecular pathways that cancer cells exploit to grow, divide, and spread to distant organs (Hanahan & Weinberg, Cell, 2011). This "machinery" is not a single protein but a collection of diverse components, including cell cycle regulators like Cyclin-Dependent Kinases (CDKs), signaling proteins like KRAS and BRAF, and cytoskeletal elements like actin and tubulin (Yamaguchi & Condeelis, Biochimica et Biophysica Acta, 2007). These components work in concert to bypass normal growth checkpoints and facilitate the physical movement required for invasion and metastasis. Because it encompasses a wide array of distinct molecular targets, it is categorized as a biological process rather than a specific therapeutic target. Pharmacological intervention typically involves targeting specific nodes within this machinery, such as using taxanes to disrupt microtubules or kinase inhibitors to shut down growth signaling (PubChem). The therapeutic challenge lies in the fact that many of these pathways are also essential for the function of normal, healthy cells, leading to significant side effects (NIH, National Cancer Institute).

Other names

Cancer cell growth and motility pathwaysOncogenic signaling networkTumorigenic machinery

Inhibition of DNA replication, disruption of microtubule dynamics, and blockade of oncogenic signaling pathways such as PI3K/AKT and MAPK/ERK (NIH, National Cancer Institute; PubMed, PMC4127616).